Crescita Therapeutics Stock Buy Hold or Sell Recommendation
| CRRTF Stock | USD 0.45 0.00 0.00% |
Assuming the 90 days horizon and your above-average risk tolerance, our recommendation regarding Crescita Therapeutics is 'Strong Sell'. Macroaxis provides Crescita Therapeutics buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding CRRTF positions.
Check out Crescita Therapeutics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Crescita and provide practical buy, sell, or hold advice based on investors' constraints. Crescita Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
Crescita |
Execute Crescita Therapeutics Buy or Sell Advice
The Crescita recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Crescita Therapeutics. Macroaxis does not own or have any residual interests in Crescita Therapeutics or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Crescita Therapeutics' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | OK | Details | |
Volatility | Out of control | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Moves totally opposite to the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Crescita Therapeutics Trading Alerts and Improvement Suggestions
| Crescita Therapeutics is way too risky over 90 days horizon | |
| Crescita Therapeutics has some characteristics of a very speculative penny stock | |
| Crescita Therapeutics appears to be risky and price may revert if volatility continues | |
| The company reported the revenue of 16.77 M. Net Loss for the year was (1.1 M) with profit before overhead, payroll, taxes, and interest of 10.01 M. | |
| Crescita Therapeutics has accumulated about 10.5 M in cash with (1.6 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.51, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Crescita Therapeutics Returns Distribution Density
The distribution of Crescita Therapeutics' historical returns is an attempt to chart the uncertainty of Crescita Therapeutics' future price movements. The chart of the probability distribution of Crescita Therapeutics daily returns describes the distribution of returns around its average expected value. We use Crescita Therapeutics price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Crescita Therapeutics returns is essential to provide solid investment advice for Crescita Therapeutics.
| Mean Return | 15.60 | Value At Risk | 0.00 | Potential Upside | 0.00 | Standard Deviation | 72.50 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Crescita Therapeutics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Crescita Therapeutics Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Crescita Therapeutics or Pharmaceuticals sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Crescita Therapeutics' price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Crescita pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 17.29 | |
β | Beta against Dow Jones | -14.14 | |
σ | Overall volatility | 125.01 | |
Ir | Information ratio | 0.12 |
Crescita Therapeutics Volatility Alert
Crescita Therapeutics is displaying above-average volatility over the selected time horizon. Crescita Therapeutics is a potential penny stock. Although Crescita Therapeutics may be in fact a good instrument to invest, many penny pink sheets are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Crescita Therapeutics. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Crescita instrument if you perfectly time your entry and exit. However, remember that penny pink sheets that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Crescita Therapeutics Fundamentals Vs Peers
Comparing Crescita Therapeutics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Crescita Therapeutics' direct or indirect competition across all of the common fundamentals between Crescita Therapeutics and the related equities. This way, we can detect undervalued stocks with similar characteristics as Crescita Therapeutics or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of Crescita Therapeutics' fundamental indicators could also be used in its relative valuation, which is a method of valuing Crescita Therapeutics by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Crescita Therapeutics to competition |
| Fundamentals | Crescita Therapeutics | Peer Average |
| Return On Equity | 0.0318 | -0.31 |
| Return On Asset | 0.0227 | -0.14 |
| Profit Margin | 0.03 % | (1.27) % |
| Operating Margin | 0.04 % | (5.51) % |
| Current Valuation | 3.64 M | 16.62 B |
| Shares Outstanding | 20.4 M | 571.82 M |
| Shares Owned By Insiders | 7.30 % | 10.09 % |
| Price To Earning | 490.00 X | 28.72 X |
| Price To Book | 0.66 X | 9.51 X |
| Price To Sales | 0.41 X | 11.42 X |
| Revenue | 16.77 M | 9.43 B |
| Gross Profit | 10.01 M | 27.38 B |
| EBITDA | 606 K | 3.9 B |
| Net Income | (1.1 M) | 570.98 M |
| Cash And Equivalents | 10.5 M | 2.7 B |
| Cash Per Share | 0.51 X | 5.01 X |
| Total Debt | 1.71 M | 5.32 B |
| Debt To Equity | 0.09 % | 48.70 % |
| Current Ratio | 3.10 X | 2.16 X |
| Book Value Per Share | 0.97 X | 1.93 K |
| Cash Flow From Operations | (1.6 M) | 971.22 M |
| Earnings Per Share | 0.02 X | 3.12 X |
| Number Of Employees | 2 | 18.84 K |
| Beta | 2.08 | -0.15 |
| Market Capitalization | 11.42 M | 19.03 B |
| Total Asset | 28.92 M | 29.47 B |
| Z Score | 3.6 | 8.72 |
| Net Asset | 28.92 M |
Crescita Therapeutics Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Crescita . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Crescita Therapeutics Buy or Sell Advice
When is the right time to buy or sell Crescita Therapeutics? Buying financial instruments such as Crescita Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Crescita Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Restaraunts Hotels Motels Thematic Idea Now
Restaraunts Hotels Motels
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Restaraunts Hotels Motels theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Restaraunts Hotels Motels Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Crescita Pink Sheet
Crescita Therapeutics financial ratios help investors to determine whether Crescita Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Crescita with respect to the benefits of owning Crescita Therapeutics security.